Pharmacyclics LLC et al v. Sun Pharma Global FZE et al
| Pharmacyclics LLC and Janssen Biotech, Inc. |
| Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd. |
| 1:2018cv01543 |
| October 5, 2018 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 20, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 13 ANSWER to #9 Answer to Complaint, Counterclaim -- Answer to Sun's Counterclaims -- by Janssen Biotech, Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Filing 12 NOTICE OF SERVICE of Defendant Sun's Initial Invalidity Contentions on U.S. Patent No. 10,004,746 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Farnan, Kelly) |
| Filing 11 NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions filed by Janssen Biotech, Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Corporate Affiliates/Parents added per Disclosure Statement (D.I. #10 ): identifying Corporate Parent Sun Pharma Holdings, Corporate Parent Sun, Ltd. for Sun Pharma Global FZE. (fms) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.. (Metzler, Sara) |
| Filing 9 ANSWER to #1 Complaint, , COUNTERCLAIM against Janssen Biotech, Inc., Pharmacyclics LLC by Sun Pharmaceutical Industries Ltd., Sun Pharma Global FZE.(Metzler, Sara) |
| Filing 8 SUMMONS Returned Executed by Pharmacyclics LLC, Janssen Biotech, Inc.. Sun Pharmaceutical Industries Ltd. served on 10/10/2018, answer due 10/31/2018. (Tigan, Jeremy) |
| Filing 7 SUMMONS Returned Executed by Pharmacyclics LLC, Janssen Biotech, Inc.. Sun Pharma Global FZE served on 10/10/2018, answer due 10/31/2018. (Tigan, Jeremy) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Biotech, Inc. filed by Janssen Biotech, Inc. (crb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Pharmacyclics LLC filed by Pharmacyclics LLC. (crb) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,004,746 B2. (crb) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/23/18. Date of Expiration of Patent: 6/3/2031. (crb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2475299.) - filed by Pharmacyclics LLC, Janssen Biotech, Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(crb) |
| Summons Issued with Magistrate Consent Notice attached as to Sun Pharma Global FZE on 10/5/2018; Sun Pharmaceutical Industries Ltd. on 10/5/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (crb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
